Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Goodsell

Showing results (61-70 of 242) with videos related to

Pageof 25
Sort By:
The Oncologist|April 19, 2002
The molecular perspective: tamoxifen and the estrogen receptorDavid S Goodsell
Stem Cells (Dayton, Ohio)|October 20, 1999
The molecular perspective: methotrexateD S Goodsell
The Oncologist|January 13, 2000
The molecular perspective: matrix metalloproteinase 2D S Goodsell
The Oncologist|September 7, 1999
The molecular perspective: methotrexateD S Goodsell
The Oncologist|May 5, 2000
The molecular perspective: cyclooxygenase-2D S Goodsell
Stem Cells (Dayton, Ohio)|February 8, 2000
The molecular perspective: matrix metalloproteinase 2D S Goodsell
The Oncologist|October 21, 2000
The molecular perspective: caspasesD S Goodsell
Stem Cells (Dayton, Ohio)|November 29, 2002
The molecular perspective: cadherinDavid S Goodsell
Stem Cells (Dayton, Ohio)|January 17, 2003
The molecular perspective: VEGF and angiogenesisDavid S Goodsell
The Oncologist|February 13, 2001
The molecular perspective: targeted toxinsD S Goodsell
Pageof 25

Showing results (61-70 of 242) with videos related to

Sort By:
Pageof 25
The Oncologist|April 19, 2002
The molecular perspective: tamoxifen and the estrogen receptorDavid S Goodsell
Stem Cells (Dayton, Ohio)|October 20, 1999
The molecular perspective: methotrexateD S Goodsell
The Oncologist|January 13, 2000
The molecular perspective: matrix metalloproteinase 2D S Goodsell
The Oncologist|September 7, 1999
The molecular perspective: methotrexateD S Goodsell
The Oncologist|May 5, 2000
The molecular perspective: cyclooxygenase-2D S Goodsell
Stem Cells (Dayton, Ohio)|February 8, 2000
The molecular perspective: matrix metalloproteinase 2D S Goodsell
The Oncologist|October 21, 2000
The molecular perspective: caspasesD S Goodsell
Stem Cells (Dayton, Ohio)|November 29, 2002
The molecular perspective: cadherinDavid S Goodsell
Stem Cells (Dayton, Ohio)|January 17, 2003
The molecular perspective: VEGF and angiogenesisDavid S Goodsell
The Oncologist|February 13, 2001
The molecular perspective: targeted toxinsD S Goodsell
Pageof 25